SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-21-069159
Filing Date
2021-12-10
Accepted
2021-12-10 21:42:15
Documents
2
Period of Report
2021-12-08

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 25993
2 POA DOCUMENT poa.txt EX-24 2378
  Complete submission text file 0001209191-21-069159.txt   29880
Mailing Address 41S RIO GRANDE STREET SALT LAKE CITY UT 84101
Business Address 41S RIO GRANDE STREET SALT LAKE CITY UT 84101 (385) 269-0203
RECURSION PHARMACEUTICALS, INC. (Issuer) CIK: 0001601830 (see all company filings)

IRS No.: 464099738 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O RECURSION PHARMACEUTICALS 41 S. RIO GRANDE STREET SALT LAKE CITY UT 84101
Business Address
Gibson Christopher (Reporting) CIK: 0001856369 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40323 | Film No.: 211486819